$MBX has generated 8 mentions over the past 12 months from 2 distinct FinTwit voices, with the first mention appearing on September 19, 2025. @adamfeuerstein accounts for 6 of these mentions, while @yasutaketin contributed 2 mentions. The most recent discussion occurred on December 23, 2025, when @yasutaketin identified $MBX as a biopharmaceutical company developing innovative peptide therapies for rare and endocrine diseases, and noted it as one of the top-performing long positions in their portfolio alongside other holdings.